Overview

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and efficacy of high and low strength of ME1111 solutions compared to the vehicle in the treatment of onychomycosis of the toenail.
Phase:
Phase 2
Details
Lead Sponsor:
Meiji Seika Pharma Co., Ltd.
Treatments:
Pharmaceutical Solutions